Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 5/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11345905 | 0.82 | MIF (0.42) | MIFCHRNA7ACHETDP1TRPA1 | |
| SCHEMBL29296 | 0.77 | CHRNA7 (0.38) | CHRNA7ACHETDP1ALDH1A1CYP2A6 | |
| SCHEMBL8762415 | 0.77 | MIF (0.42) | MIFCHRNA7ACHETDP1TRPA1 | |
| SCHEMBL2001199 | 0.76 | MIF (0.61) | MIFTRPA1ALDH1A1CYP2A6 | |
| SCHEMBL11337190 | 0.75 | MIF (0.55) | MIFCHRNA7ACHECYP19A1SMN1; SMN2 | |
| SCHEMBL18422141 | 0.75 | MIF (0.46) | MIFACHETDP1ALDH1A1CYP19A1 | |
| SCHEMBL10903921 | 0.72 | MIF (0.39) | MIFACHEALDH1A1SMN1; SMN2 | |
| SCHEMBL8762285 | 0.69 | MIF (0.78) | MIFTRPA1TRPV1 | |
| SCHEMBL8764131 | 0.68 | MIF (0.49) | MIFCHRNA7ACHETDP1TRPA1 | |
| SCHEMBL332260 | 0.64 | MIF (0.56) | MIFACHETDP1ALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552745-B2 | Compound for optical materials, curable composition, cured body, and optical article | TOKUYAMA CORPORATION (JP) | 2026-02-17 | — | — | US | disclosed |
| EP-4679147-A1 | MULTILAYER BODY, OPTICAL ARTICLE, COATING LAYER-CONTAINING MULTILAYER BODY, LENS, EYEGLASSES, AND FILM FOR WINDOWS | TOKUYAMA CORPORATION (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20250355282-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-11-20 | — | — | US | disclosed |
| US-20250257162-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-4560367-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-05-28 | — | — | EP | disclosed |
| EP-4516823-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-03-05 | — | — | EP | disclosed |
| CN-119072504-A | Curable composition, cured product, laminate, optical article, lens, and glasses | 株式会社德山 | 2024-12-03 | — | — | CN | disclosed |
| WO-2024080103-A1 | OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | 株式会社トクヤマ | 2024-04-18 | — | — | WO | disclosed |
| US-20240100810-A1 | RESIN COMPOSITION, OPTICAL LAMINATE, OPTICAL ARTICLE, LENS AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2024-03-28 | — | — | US | disclosed |
| US-11912813-B2 | Urethane resin using polyrotaxane, and pad for polishing | TOKUYAMA CORPORATION (JP) | 2024-02-27 | — | — | US | disclosed |
| EP-2049591-A1 | BIOCOMPATIBLE POLYMER COMPOSITIONS | Polynovo Biomaterials Pty Limited (AU) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008014561-A1 | BIOCOMPATIBLE POLYMER COMPOSITIONS | POLYNOVO BIOMATERIALS PTY LTD (AU) | 2008-02-07 | — | — | WO | disclosed |
| WO-2004011506-A1 | A HIGH REFRACTIVE INDEX POLYMERIZABLE COMPOSITION | PPG INDUSTRIES OHIO, INC. (US) | 2004-02-05 | — | — | WO | disclosed |
| EP-1265938-A1 | OPTICAL RESIN COMPOSITION | PPG Industries Ohio, Inc. (US) | 2002-12-18 | — | — | EP | disclosed |
| EP-1250370-A1 | METHOD OF PREPARING AN OPTICAL POLYMERIZATE | PPG Industries Ohio, Inc. (US) | 2002-10-23 | — | — | EP | disclosed |
| EP-1250369-A1 | METHOD OF PREPARING AN OPTICAL POLYMERIZATE | PPG Industries Ohio, Inc. (US) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001036506-A1 | OPTICAL RESIN COMPOSITION | PPG INDUSTRIES OHIO, INC. (US) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001036507-A1 | METHOD OF PREPARING AN OPTICAL POLYMERIZATE | PPG INDUSTRIES OHIO, INC. (US) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001036508-A1 | METHOD OF PREPARING AN OPTICAL POLYMERIZATE | PPG INDUSTRIES OHIO, INC. (US) | 2001-05-25 | — | — | WO | disclosed |
| US-5622826-A | COUPLING WITH AN ISOCYANATE OR ISOTHIOCYANATE | HOUSTON ADVANCED RESEARCH CENTER (US) | 1997-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552745-B2 | Compound for optical materials, curable composition, cured body, and optical article | C5, SCO2, ZYX | MIF 2478/4885CHRNA7 2044/4885ACHE 1259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.